Oncology Clinical Trials in Grand Rapids, MI

As of August 2026, 178 paid clinical trials are recruiting for Oncology in Grand Rapids, Michigan. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: August 31, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

180 clinical trials for Oncology

·Clear filters·

Email me when a new oncology trial opens in Grand Rapids, MI.

A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies

for Advanced Solid Tumor

Sites in Grand Rapids +5 more locations

Sponsor: Ipsen

Sex: All·Age: 18+

Code: NCT07213830·Phase 1, Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)

for Metastatic Castration-resistant Prostate Cancer

Sites in Grand Rapids +8 more locations

Sponsor: Daiichi Sankyo

Sex: Male·Age: 18+

Code: NCT07244341·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors

for Advanced Solid Tumor, Adult

Sites in Grand Rapids +5 more locations

Sponsor: Cogent Biosciences, Inc.

Sex: All·Age: 18+

Code: NCT07361562·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

A Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors

for Gastrointestinal Cancer

Sites in Grand Rapids +3 more locations

Sponsor: DualityBio Inc.

Sex: All·Age: 18+

Code: NCT07263594·Phase 1, Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors.

for Advanced Solid Tumors

Sites in Grand Rapids +7 more locations

Sponsor: FoRx Therapeutics AG

Sex: All·Age: 18+

Code: NCT07356453·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

for Solid Tumor

Sites in Grand Rapids +9 more locations

Sponsor: STORM Therapeutics LTD

Sex: All·Age: 18+

Code: NCT06975293·Phase 1, Phase 2·Recruiting·Listed May 2025

Apply to this trial

TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas

for Lymphoma

Sites in Grand Rapids +7 more locations

Sponsor: Treeline Biosciences, Inc.

Sex: All·Age: 18+

Code: NCT07082803·Phase 1·Recruiting·Listed Jul 2025

Apply to this trial

A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers

for Colorectal Neoplasms

Sites in Grand Rapids +5 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT06663319·Phase 1·Recruiting·Listed Oct 2024

Apply to this trial

Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)

for Colorectal Cancer

1 location in Grand Rapids

Sponsor: GE Healthcare

Sex: All·Age: 18+

Code: NCT07219238·Phase 2, Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Study of JNJ-87890387 for Advanced Solid Tumors

for Neoplasms

Sites in Grand Rapids +1 more location

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT06178614·Phase 1·Recruiting·Listed Dec 2023

Apply to this trial

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Grand Rapids, Ann Arbor +13 more locations

Sponsor: Vividion Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06004245·Phase 1·Recruiting·Listed Aug 2023

Apply to this trial

A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors

for Solid Tumor

Drug: PT0253

Sites in Grand Rapids +6 more locations

Sponsor: PAQ Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06797336·Phase 1·Recruiting·Listed Jan 2025

Apply to this trial

A Study of MGC026 in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Grand Rapids +6 more locations

Sponsor: MacroGenics

Sex: All·Age: 18+

Code: NCT06242470·Phase 1·Recruiting·Listed Feb 2024

Apply to this trial

Study of AUBE00 in Patients With Solid Tumors

for Solid Tumors

Sites in Grand Rapids +1 more location

Sponsor: Chugai Pharmaceutical

Sex: All·Age: 18+

Code: NCT07030959·Phase 1·Recruiting·Listed Jun 2025

Apply to this trial

A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours

for Advanced Solid Tumor

Sites in Grand Rapids +4 more locations

Sponsor: Ipsen

Sex: All·Age: 18+

Code: NCT06833008·Phase 1, Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

for Acute Myeloid Leukemia

Sites in Grand Rapids +6 more locations

Sponsor: Debiopharm International SA

Sex: All·Age: 18+

Code: NCT06969430·Phase 1, Phase 2·Recruiting·Listed May 2025

Apply to this trial

ARC101 in Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Grand Rapids +1 more location

Sponsor: Third Arc Bio

Sex: All·Age: 18+

Code: NCT06672185·Phase 1·Recruiting·Listed Nov 2024

Apply to this trial

Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

for Gastroesophageal Junction

Sites in Grand Rapids +5 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06469944·Phase 1, Phase 2·Recruiting·Listed Jun 2024

Apply to this trial

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

for Head and Neck Squamous Cell Carcinoma (HNSCC)

Sites in Grand Rapids +5 more locations

Sponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT05985655·Phase 1, Phase 2·Recruiting·Listed Aug 2023

Apply to this trial

A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)

for Advanced Solid Tumors

Drug: Calderasib

Sites in Grand Rapids +4 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT05067283·Phase 1·Recruiting·Listed Oct 2021

Apply to this trial

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

for Pancreatic Ductal Adenocarcinoma

Sites in Grand Rapids +8 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 100

Code: NCT06562192·Phase 1·Recruiting·Listed Aug 2024

Apply to this trial

A Study of LY4170156 in Participants With Selected Advanced Solid Tumors

for Ovarian Neoplasms

Sites in Grand Rapids +8 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT06400472·Phase 1·Recruiting·Listed May 2024

Apply to this trial

Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)

for Gastroesophageal Junction

Sites in Grand Rapids +5 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06445972·Phase 1, Phase 2·Recruiting·Listed Jun 2024

Apply to this trial

A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

for Metastatic Colorectal Cancer

Drug: Pumitamig

Sites in Grand Rapids +3 more locations

Sponsor: BioNTech SE

Sex: All·Age: 18+

Code: NCT07079631·Phase 1, Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

A Study of ZW251 in Participants With Advanced Solid Tumors

for Hepatocellular Carcinoma

Sites in Grand Rapids +7 more locations

Sponsor: Zymeworks BC Inc.

Sex: All·Age: 18+

Code: NCT07164313·Phase 1·Recruiting·Listed Sep 2025

Apply to this trial

CT-95 in Advanced Cancers Associated With Mesothelin Expression

for Mesothelin-Expressing Tumors

Sites in Grand Rapids +8 more locations

Sponsor: Context Therapeutics Inc.

Sex: All·Age: 18+

Code: NCT06756035·Phase 1·Recruiting·Listed Jan 2025

Apply to this trial

A Study of MGC028 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Grand Rapids +6 more locations

Sponsor: MacroGenics

Sex: All·Age: 18+

Code: NCT06723236·Phase 1·Recruiting·Listed Dec 2024

Apply to this trial

A Study of Lorigerlimab in Participants With Advanced Solid Tumors

for Platinum-resistant Ovarian Cancer

Sites in Grand Rapids +6 more locations

Sponsor: MacroGenics

Sex: Female·Age: 18+

Code: NCT06730347·Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

for NSCLC (Advanced Non-small Cell Lung Cancer)

Sites in Grand Rapids, Farmington Hills +6 more locations

Sponsor: ALX Oncology Inc.

Sex: All·Age: 18+

Code: NCT07085091·Phase 1·Recruiting·Listed Jul 2025

Apply to this trial

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

for Castration-Resistant Prostate Cancer (CRPC)

Sites in Grand Rapids +3 more locations

Sponsor: Radiopharm Theranostics, Ltd

Sex: All·Age: 18+

Code: NCT07189871·Phase 1, Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors

for Solid Tumors

Sites in Grand Rapids +8 more locations

Sponsor: Exelixis

Sex: All·Age: 18+

Code: NCT07123103·Phase 1·Recruiting·Listed Aug 2025

Apply to this trial

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Grand Rapids +6 more locations

Sponsor: Vividion Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06804824·Phase 1·Recruiting·Listed Feb 2025

Apply to this trial

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

for Prostate Cancer Castration-resistant Prostate Cancer

Sites in Grand Rapids +6 more locations

Sponsor: MBrace Therapeutics

Sex: All·Age: 18+

Code: NCT07145255·Phase 1, Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

A Study of YL242 in Subjects With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Grand Rapids +6 more locations

Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All·Age: 18+

Code: NCT07197827·Phase 1, Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Grand Rapids +6 more locations

Sponsor: BioNTech SE

Sex: All·Age: 18+

Code: NCT06750185·Phase 1·Recruiting·Listed Dec 2024

Apply to this trial

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

for Advanced or Metastatic ER+ HER2- Breast Cancer (mBC)

Sites in Grand Rapids +6 more locations

Sponsor: Olema Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT06784193·Phase 1·Recruiting·Listed Jan 2025

Apply to this trial

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

for Head and Neck Squamous Cell Carcinoma (HNSCC)

Sites in Grand Rapids +3 more locations

Sponsor: Tanabe Pharma America, Inc.

Sex: All·Age: 18+

Code: NCT06943521·Phase 1, Phase 2·Recruiting·Listed Apr 2025

Apply to this trial

64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer

for Metastatic Sarcoma

Sites in Grand Rapids +4 more locations

Sponsor: Lantheus Medical Imaging

Sex: All·Age: 15+

Code: NCT06298916·Phase 1, Phase 2·Recruiting·Listed Mar 2024

Apply to this trial

A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors

for Solid Tumors

Sites in Grand Rapids +7 more locations

Sponsor: Adcentrx Therapeutics

Sex: All·Age: 18+

Code: NCT06710379·Phase 1·Recruiting·Listed Nov 2024

Apply to this trial

Trial to Evaluate Safety, PD & PK of IV Study Drug, QN-302, in Pts w/ Advanced or Metastatic Solid Tumors

for Solid Tumor

Sites in Grand Rapids +3 more locations

Sponsor: Qualigen Theraputics, Inc.

Sex: All·Age: 18+

Code: NCT06086522·Phase 1·Recruiting·Listed Oct 2023

Apply to this trial

Conditions in Oncology (Grand Rapids, MI)

Solid tumor· 48 Non-small cell lung cancer (NSCLC)· 30 Colorectal cancer· 28 Breast cancer· 16 Pancreatic cancer· 15 Ovarian cancer· 13 Cancer (any)· 11 Gastric cancer· 10 Bladder cancer· 10 Endometrial cancer· 9 Prostate cancer· 8 Melanoma· 8 Triple-negative breast cancer· 7 Esophageal cancer· 7 Biliary tract cancer· 6 Multiple myeloma· 6 Acute myeloid leukemia (AML)· 6 Non-Hodgkin lymphoma· 6 Hematologic malignancy· 6 Head and neck cancer· 6 Metastatic breast cancer· 5 Gastroesophageal junction cancer· 5 Kidney cancer· 5 Cervical cancer· 5 Chronic lymphocytic leukemia (CLL)· 5 Diffuse large B-cell lymphoma (DLBCL)· 5 Liver cancer· 4 Metastatic prostate cancer· 4 Sarcoma· 4 Neuroblastoma· 4 Leukemia (other)· 3 Small lymphocytic lymphoma· 3 Ewing sarcoma· 3 Small cell lung cancer· 2 Metastatic colorectal cancer· 2 Acute lymphoblastic leukemia· 2 Myelodysplastic syndromes (MDS)· 2 Hodgkin lymphoma· 2 HER2-positive breast cancer· 1 Colon cancer· 1 Rectal cancer· 1 Gastrointestinal cancer· 1 Uterine cancer· 1 Fallopian tube cancer· 1 Glioma· 1 Brain metastases· 1 Chronic myelomonocytic leukemia· 1 Myeloproliferative neoplasm· 1 Mantle cell lymphoma· 1 Burkitt lymphoma· 1 Thyroid cancer· 1 Soft tissue sarcoma· 1 Osteosarcoma· 1 Rhabdomyosarcoma· 1 Mesothelioma· 1 Neuroendocrine tumors· 1